Rafael (NYSE:RFL) Trading Up 2.6% – Still a Buy?

Rafael Holdings, Inc. (NYSE:RFL) was up 2.6% during trading on Monday . The company traded as high as $1.47 and last traded at $1.47. Approximately 67,086 shares changed hands during mid-day trading, an increase of 44% from the average daily volume of 46,522 shares. The stock had previously closed at $1.43.

Rafael Stock Up 2.6%

The stock has a 50-day moving average of $1.58 and a 200 day moving average of $1.80. The stock has a market cap of $36.56 million, a PE ratio of -0.88 and a beta of 1.01.

Rafael (NYSE:RFL) last issued its earnings results on Thursday, March 13th. The company reported ($0.06) EPS for the quarter. The firm had revenue of $0.08 million during the quarter. Rafael had a negative net margin of 5,707.03% and a negative return on equity of 53.71%.

Institutional Investors Weigh In On Rafael

Hedge funds have recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC purchased a new stake in Rafael in the 1st quarter worth approximately $26,000. Geode Capital Management LLC boosted its position in Rafael by 17.9% in the 4th quarter. Geode Capital Management LLC now owns 174,561 shares of the company’s stock worth $288,000 after purchasing an additional 26,493 shares in the last quarter. Ieq Capital LLC purchased a new stake in Rafael in the 1st quarter worth approximately $447,000. Finally, Peapod Lane Capital LLC purchased a new stake in Rafael in the 4th quarter worth approximately $553,000. Hedge funds and other institutional investors own 11.30% of the company’s stock.

Rafael Company Profile

Rafael Holdings, Inc primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.